| n | Adenocarcinoma | SCC |
---|---|---|---|
Patients | 283 | Â | Â |
Age (years) | |||
 Median | 78 (range 52–90) | 79 (52–89) | 77.5 (52–90) |
Gender | |||
 Male | 214 | 124 | 74 |
 Female | 69 | 61 | 6 |
Performance status | |||
 0 | 58 | 40 | 13 |
 1 | 184 | 124 | 51 |
 2 | 37 | 19 | 14 |
 3 | 3 | 1 | 2 |
 Unknown | 1 | 1 | 0 |
Observation period (months) | |||
 Median | 28 (range 0–127) | 30 (0–127) | 25 (2–101) |
Institutions | |||
 A | 155 | 97 | 45 |
 B | 67 | 47 | 16 |
 C | 41 | 25 | 14 |
 D | 23 | 16 | 5 |
Maximum tumor diameter (mm) | |||
 Median | 24 (range 9–65) | 23 (9–65) | 26 (13–65) |
Number of tumors | |||
 1 | 280 | - | - |
 2 | 3 | - | - |
T stage | |||
 1a and 1b | 195 | 131 | 51 |
 2a and 2b | 91 | 54 | 29 |
Tumor location | |||
 Right Upper Lobe | 74 | 54 | 15 |
 Right Middle Lobe | 18 | 10 | 7 |
 Right Lower Lobe | 69 | 45 | 21 |
 Left Upper Lobe | 75 | 47 | 24 |
 Left Lower Lobe | 50 | 29 | 13 |
Operability | |||
 Operable | 71 | 49 | 16 |
 Inoperable | 190 | 120 | 55 |
 Unknown | 25 | 16 | 9 |